A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.

R. M. Rifkin, E. M. Hersh, S. E. Salmon

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds